WASHINGTON, DC — Members of the House Judiciary Committee on Thursday voted in favor of legislation (HR 5634: The Medical Cannabis Research Act of 2018) to facilitate federally-approved clinical trials assessing the efficacy of whole-plant cannabis. The vote marks the first time that lawmakers have ever decided in favor of easing existing federal restrictions which limit investigators ability to clinically […]
HARRISBURG, PA — Democrat Governor Tom Wolf has signed legislation into law to facilitate state-sponsored medical cannabis research. The amended law, House Bill 2477, states: “It is the intention of the General Assembly to create a mechanism whereby this Commonwealth’s medical schools and hospitals may provide advice to grower/processors and dispensaries in the areas of patient health and safety, […]
MADISON, WI — Members of the Wisconsin Assembly and Senate have unanimously approved legislation, Senate Bill 119, to establish a state-sponsored pilot program to “study the growth, cultivation, and marketing of industrial hemp.” The measure now awaits final approval from Republican Gov. Scott Walker. Under a 2014 federal law, states may license hemp cultivation as part of a university sponsored […]
The American Legion has been calling on the federal government for over a year – specifically the Veterans Affairs Department – to support research into the therapeutic benefits of cannabis in treating veterans with PTSD. Many veterans have said that they have been able to eliminate or reduce their dependency on other drugs, specifically opioids, […]
SANTA FE, NM — New Mexico Governor Susana Martinez has vetoed a pair of measures that sought to establish a hemp research program through the state’s Department of Agriculture. The Governor gave no public explanation for the vetoes. The Governor has historically been an outspoken opponent of marijuana law reform efforts – receiving an ‘F’ […]
Kentucky gears up for third year of hemp research projects
The Kentucky Department of Agriculture started these industrial hemp research projects to study production, processing and potential products. "It's important to note that Kentucky, back in 2014 reintroduced a crop that had not been seen for decades," …
Read more on WBKO
Nike Brings Back Hemp Sneaker for 4/20
Currently, millions of dollars worth of hemp are imported every year for American industries. Companies like Nike use hemp fibers in sneakers; our automobile industry uses hemp fibers to produce plastic and car door panelling. In 2014, we spent an …
Read more on Ora TV
Ottawa, ON (PRWEB) February 12, 2015
Vida Cannabis Corp. today announced the official launch of its new website vidacannabis.com. Vida’s site serves as an information resource for the growing number of Canadians who are utilizing legal medical cannabis to treat a multitude of ailments.
The site includes a Learning Centre that addresses questions for patients and doctors about the types of conditions that can be treated with cannabis, how cannabis works, who cannabis helps, and the future of cannabis based medicine.
“We want doctors, patients and stakeholders to learn about all aspects of medical cannabis through powerful videos, concise explanations and our downloadable e-booklet,” said Greg Wilson, Vida Cannabis CEO. “Our goal is to engage, educate, inform and then facilitate access for Canadians to receive the best quality medicine. We believe our new website demonstrates the experience, expertise, professionalism and dedication of the entire Vida team.”
The site features HD videos showcasing Vida’s 315,000-square-foot production facility in Stellarton, Nova Scotia, and its industry leading level-10 security protocols that are directed by former RCMP Chief Superintendent Derek Ogden, Vida’s Chief Operating Officer.
Vida’s emphasis on science and research also come into focus on the new site. Dr. Pritesh Kumar, Vida’s Chief Cannabinoid Research Scientist & Quality Assurance Manager, leads the research team. His entire career is focused on understanding the bioactive components of the cannabis plant. Honoured for his research publications and respected for his innovative research design, Dr. Kumar is at the forefront of the quest to bring 21st century cellular level understanding to the medicinal properties of cannabinoids.
On the cultivation side, Vida has brought together five of the most talented growers from Canada’s west-coast. Known as “The Vida 5” the team is led by Head Master Cultivator Stephen Schroeder.
“Vida shares our standards of integrity and compassion. Our new hydroponic facility is a grower’s dream come true,” says Schroeder.
About Vida Cannabis:
Vida Cannabis Corp. is working to develop uniquely high quality solutions to meet customer needs in the growing global marketplace for legal cannabis-based products. Initial operations are centered in the Canadian market, where the Federal Government has established national guidelines enabling best-in-class producers to acquire commercial production licenses for medicinal purposes. Vida has assembled one of the top management teams in the world, and has extensive access to expertise and resources in the United States, Canada and Europe. Its 315,000-square-foot production facility, located in Stellarton, Nova Scotia, will be one of the largest, most advanced medical marijuana facilities in Canada.
This announcement does not constitute or form part of, and shall under no circumstances be considered as, an offer to sell, a solicitation to purchase, or advice on investments in any securities of Vida Cannabis Corp. (“Vida Cannabis”). Offers and solicitations shall be expressly identified as such and made in compliance with applicable securities laws. This announcement is for information purposes only. It should not be relied upon as a basis for investment decisions. You should consult with your own investment, accounting, legal and tax advisers to evaluate independently the risks, consequences and suitability of any investments you are considering. Whilst the information provided here is believed to be reliable, it cannot be guaranteed. It may contain forward-looking statements made by or on behalf of Vida Cannabis about its business or financial objectives, position, strategies or expectations. Such forward-looking statements may be identified by words such as, or similar to, “intends,” “anticipates,” “believes,” “expects” and “hopes” and includes, without limitation, the development of production facilities, approval from regulatory authorities and the ability for Vida Cannabis to obtain adequate financing to meet its business objectives. These statements involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated. The statements in this announcement do not guarantee future performance. Vida Cannabis does not undertake any obligation to update any information provided in this announcement. In Canada, Vida Cannabis (Canada) Ltd., a wholly owned subsidiary of Vida Cannabis, must obtain approval from Health Canada in order to operate as a licensed commercial producer under the Marihuana for Medical Purposes Regulations. Vida Cannabis makes no representations or warranties that it will receive Health Canada approval.
New York, NY (PRWEB) April 09, 2015
The Medical and Recreational Marijuana Growing industry has flourished over the five years to 2015. For decades, all marijuana transactions in the United States were conducted under implicit or explicit prohibition. However, states have increasingly moved to legalize nonprofit marijuana for medical purposes, as well as to implement regulations for organizations that sell cannabis. “The growing acceptance of medical marijuana is providing growers and investors with unprecedented opportunities,” says IBISWorld Industry Analyst Dmitry Diment. “There has been no shortage of demand in recent years, as the industry has benefited from increased acceptance of the legitimacy of medical marijuana products.”
Recently, the legalization of recreational marijuana in Colorado and Washington has spurred additional demand for the industry. In 2014, the licensing of commercial recreational marijuana growers in these states contributed to industry revenue growth of 54.7%. In addition to the favorable regulatory environment in these states, medical marijuana growers have continued to benefit from the steadily aging population. Chronic illnesses have become more prevalent as the population continues to age, driving demand for medical marijuana. Overall, the industry is expected to experience annualized revenue growth of 30.2% to $ 1.9 billion in the five years to 2015, including growth of 25.1% during the current year.
According to Diment, however, “The industry will remain at risk until the federal government definitively changes its position on the legality of marijuana. Until then, a growing number of medical marijuana patients, as well as a burgeoning recreational cannabis legalization movement, will spur demand for the industry.” Rising demand is also forecast to widen profit margins, as is the success of the for-profit recreational marijuana business in Colorado and Washington. In particular, the next five years are expected to see the growth of large commercial cultivators, who will benefit from strong recreational demand across a number of states, including Alaska, Oregon and the District of Columbia.
For more information, visit IBISWorld’s Medical and Recreational Marijuana Growing in the US industry report page.
Follow IBISWorld on Twitter: https://twitter.com/#!/IBISWorld
Friend IBISWorld on Facebook: http://www.facebook.com/pages/IBISWorld/121347533189
IBISWorld industry Report Key Topics
This industry’s establishments grow marijuana for medical and recreational use. Most operators are nonprofit collectives that provide medical marijuana to other collective members. Transactions are typically conducted on a donation basis because the sale and distribution of marijuana is illegal in most states that permit medical marijuana. The industry also includes operators in Colorado and Washington, who grow medical and recreational marijuana on a for-profit basis.
Key External Drivers
Industry Life Cycle
Products & Markets
Products & Services
Globalization & Trade
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Barriers to Entry
About IBISWorld Inc.
Recognized as the nation’s most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on every US industry. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in Los Angeles, IBISWorld serves a range of business, professional service and government organizations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com or call 1-800-330-3772.
Bradley University’s Dr. Luke Haverhals, Assistant Professor of Chemistry, discusses his research on natural fibers and how hemp can be used for fiberglass in cars, building materials and many other sustainable products. #Hemp
Source: Chicago Tribune, Abel Uribe
Footage: Campaign for the Restoration and Regulation of Hemp (CRRH) http://hemp.org
Video Rating: 5 / 5
Watch in HD!!
this is basically my review on this product please enjoy! 🙂
Disclaimer: this is my honest opinion on this product, i purchased this product with my own money i am not being paid to review this product
Virginia Tech to research production, use, and economic impact of industrial hemp
vtech-logo Virginia Tech will be able to begin research on growing industrial hemp in the commonwealth as a result of a new state law and the establishment of an industrial hemp research program by the Virginia Department of Agriculture and Consumer …
Read more on Augusta Free Press
Bill to Legalize Hemp Farming, Nullify Federal Ban, Passes Washington House …
…allows State Agriculture Departments, colleges and universities to grow hemp, defined as the non-drug oilseed and fiber varieties of Cannabis, for academic or agricultural research purposes, but it applies only to states where industrial hemp farming …
Read more on Tenth Amendment Center (blog)